Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1976
American Assets Trust
AAT
$1.48B
| $511K | ﹤0.01% |
22,704
-31
| -0.1% | -$614 |
|
1977
National Beverage
FIZZ
$3B
| $511K | ﹤0.01% |
10,286
-18
| -0.2% | -$861 |
|
1978
Caleres
CAL
$437M
| $507K | ﹤0.01% |
16,507
-30
| -0.2% | -$846 |
|
1979
Tilray
TLRY
$572M
| $506K | ﹤0.01% |
21,939
| – | – |
|
|
NTST
1980
NETSTREIT Corp
NTST
$2.1B
| $506K | ﹤0.01% |
28,332
-44
| -0.2% | -$690 |
|
1981
Protagonist Therapeutics
PTGX
$8.92B
| $499K | ﹤0.01% |
21,734
-41
| -0.2% | -$717 |
|
1982
Manhattan Associates
MANH
$11.1B
| $498K | ﹤0.01% |
2,314
-48
| -2% | -$10.2K |
|
1983
Kaiser Aluminum
KALU
$2.61B
| $497K | ﹤0.01% |
6,973
-13
| -0.2% | -$824 |
|
1984
VSE Corp
VSEC
$5.37B
| $496K | ﹤0.01% |
7,681
-2,422
| -24% | -$142K |
|
|
FBRT
1985
Franklin BSP Realty Trust
FBRT
$643M
| $494K | ﹤0.01% |
36,537
-62
| -0.2% | -$817 |
|
1986
Weis Markets
WMK
$1.92B
| $492K | ﹤0.01% |
7,702
-13
| -0.2% | -$827 |
|
|
BVH
1987
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $492K | ﹤0.01% |
6,547
-8
| -0.1% | -$466 |
|
|
UMH
1988
UMH Properties
UMH
$1.3B
| $492K | ﹤0.01% |
32,114
-38
| -0.1% | -$548 |
|
|
CYBR
1989
DELISTED
CyberArk
CYBR
| $491K | ﹤0.01% |
2,239
| – | – |
|
|
PGRE
1990
DELISTED
Paramount Group
PGRE
| $489K | ﹤0.01% |
94,540
-211
| -0.2% | -$1K |
|
1991
Employers Holdings
EIG
$941M
| $488K | ﹤0.01% |
12,371
-22
| -0.2% | -$856 |
|
1992
PRA Group
PRAA
$662M
| $487K | ﹤0.01% |
18,579
-32
| -0.2% | -$599 |
|
|
JAMF
1993
DELISTED
Jamf
JAMF
| $487K | ﹤0.01% |
26,937
-34
| -0.1% | -$574 |
|
1994
Aspen Aerogels
ASPN
$374M
| $486K | ﹤0.01% |
30,805
-54
| -0.2% | -$558 |
|
1995
Comstock Resources
CRK
$3.73B
| $486K | ﹤0.01% |
54,831
-331
| -0.6% | -$3.58K |
|
1996
Columbus McKinnon
CMCO
$596M
| $485K | ﹤0.01% |
12,428
-22
| -0.2% | -$772 |
|
1997
Kymera Therapeutics
KYMR
$8.8B
| $485K | ﹤0.01% |
19,056
-35
| -0.2% | -$626 |
|
1998
DraftKings
DKNG
$11.8B
| $484K | ﹤0.01% |
13,718
-295
| -2% | -$9.87K |
|
1999
LeMaitre Vascular
LMAT
$2.34B
| $483K | ﹤0.01% |
8,512
-16
| -0.2% | -$838 |
|
|
MFA
2000
MFA Financial
MFA
$935M
| $483K | ﹤0.01% |
42,817
-77
| -0.2% | -$778 |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.